332133-92-3 Usage
Uses
Used in Organic Synthesis:
4-(Tributylstannyl)pyrimidine is used as a reagent for the introduction of the pyrimidine moiety into organic molecules, leveraging its tributylstannyl group's reactivity in cross-coupling reactions. This application is crucial for the synthesis of complex molecular structures.
Used in Pharmaceutical Production:
In the pharmaceutical industry, 4-(Tributylstannyl)pyrimidine is utilized as a key intermediate in the synthesis of various drugs. Its ability to form cross-coupled products with other organic compounds aids in the development of new medicinal agents.
Used in Agrochemical Development:
Similarly, in agrochemicals, 4-(Tributylstannyl)pyrimidine serves as a precursor in the synthesis of compounds with pesticidal or herbicidal properties, contributing to the advancement of crop protection strategies.
Used in Research and Development for Materials:
4-(Tributylstannyl)pyrimidine is also employed in the research and development of new materials, where its unique properties can be harnessed to create innovative substances for various applications, including but not limited to, advanced materials for electronics, coatings, or other industrial uses.
Check Digit Verification of cas no
The CAS Registry Mumber 332133-92-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,2,1,3 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 332133-92:
(8*3)+(7*3)+(6*2)+(5*1)+(4*3)+(3*3)+(2*9)+(1*2)=103
103 % 10 = 3
So 332133-92-3 is a valid CAS Registry Number.
332133-92-3Relevant articles and documents
SUBSTITUTED [5,6]CYCLIC-4(3H)-PYRIMIDINONES AS ANTICANCER AGENTS
-
Page/Page column 43; 45, (2018/12/13)
The present invention relates to novel substituted [5,6]cyclic-4(3H)-pyrimidinone compounds of formula (I) and their preparation methods. (I) In particular, the present invention relates to novel substituted [5,6]cyclic-4(3H)- pyrimidinone compounds useful as inhibitors of protein kinases, specifically CDC7 (cell division cycle 7) inhibitors.
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
-
Page 109, (2008/06/13)
This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
